Summary of the bill.
The bill proposes to amend five articles of Law 242 of October 13, 2021, governing medical cannabis and its derivatives. It regulates the number of manufacturing licenses, the temporary importation of derivatives, and authorized suppliers. It also provides for medication donations to low-income patients, their tax treatment, and provisions on private insurance and hospital care.